文献速递消化道肿瘤与早癌消化内镜

T1期结直肠癌内镜切除后追加手术与直接手术的长期结局比较

Long-Term Outcomes of Additional Surgery After Endoscopic Resection Versus Primary Surgery for T1 Colorectal Cancer.
PubMed 文献 · Am J Gastroenterol · 2024-06-12

本研究基于日本27家高容量机构2009至2016年6,105例T1期结直肠癌患者,比较内镜切除后追加手术与直接手术的长期结局。倾向性评分匹配后每组1,219例,追加手术组与直接手术组5年总生存率分别为97.1%和96.0%(HR 0.72,95%CI 0.49-1.08),追加手术组非劣效;复发率分别为2.6%和2.0%,两组无显著差异(OR 1.34,95%CI 0.76-2.40,P=0.344)。

要点

  • 倾向性评分匹配后每组1,219例,追加手术组5年总生存率97.1%,直接手术组96.0%。
  • 风险比HR 0.72(95%CI 0.49-1.08),追加手术组非劣效于直接手术组。
  • 复发:追加手术组32例(2.6%),直接手术组24例(2.0%),两组无显著差异(P=0.344)。

核心结论

  • T1期结直肠癌内镜切除后追加手术对患者长期结局(包括5年总生存率)无不良影响。
  • 内镜切除是可内镜下切除的T1期结直肠癌可行的首选治疗选择。

研究设计与样本

  • 大型观察性研究,纳入2009至2016年日本27家高容量机构6,105例接受内镜切除或手术切除的T1期结直肠癌患者。
  • 仅接受手术者为直接手术组,内镜切除后追加手术者为追加手术组。
  • 采用倾向性评分匹配分析死亡与复发的长期结局。

主要发现

  • 倾向性评分匹配后,2,438例中每组各1,219例。
  • 追加手术组与直接手术组5年总生存率分别为97.1%和96.0%(HR 0.72,95%CI 0.49-1.08),追加手术组非劣效。
  • 追加手术组32例(2.6%)与直接手术组24例(2.0%)复发,两组无显著差异(OR 1.34,95%CI 0.76-2.40,P=0.344)。

关键数值与推荐

  • 5年总生存率:追加手术组97.1% vs 直接手术组96.0%(HR 0.72,95%CI 0.49-1.08)。
  • 复发率:追加手术组2.6%(32例) vs 直接手术组2.0%(24例),OR 1.34(95%CI 0.76-2.40),P=0.344。

临床怎么用

  • 原文结论认为内镜切除是可内镜下切除的T1期结直肠癌可行的首选治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There is considerable concern about whether endoscopic resection (ER) before additional surgery (AS) for T1 colorectal cancer (CRC) has oncologically potential adverse effects. Therefore, the aim of this study was to compare the long-term outcomes, including overall survival (OS), of patients treated with AS after ER vs primary surgery (PS) for T1 CRC using a propensity score-matched analysis from a large observational study. METHODS: This study investigated 6,105 patients with T1 CRC treated with either ER or surgical resection between 2009 and 2016 at 27 high-volume Japanese institutions, with those undergoing surgery alone included in the PS group and those undergoing AS after ER included in the AS group. Propensity score matching was used for long-term outcomes of mortality and recurrence analysis. RESULTS: After propensity score matching, 1,219 of 2,438 patients were identified in each group. The 5-year OS rates in the AS and PS groups were 97.1% and 96.0%, respectively (hazard ratio: 0.72, 95% confidence interval: 0.49-1.08), indicating the noninferiority of the AS group. Moreover, 32 patients (2.6%) in the AS group and 24 (2.0%) in the PS group had recurrences, with no significant difference between the 2 groups (odds ratio: 1.34, 95% confidence interval: 0.76-2.40, P = 0.344). DISCUSSION: ER before AS for T1 CRC had no adverse effect on patients' long-term outcomes, including the 5-year OS rate. ER is a viable first-line treatment option for endoscopically resectable T1 CRC.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Tamaru Y, Kuwai T, Kajiwara Y, et al. Long-Term Outcomes of Additional Surgery After Endoscopic Resection Versus Primary Surgery for T1 Colorectal Cancer. Am J Gastroenterol. 2024. PMID: 38864517. doi:10.14309/ajg.0000000000002879

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。